1st Circ. Revives Amgen Migraine Drug Risk Label Suit
A mother in Massachusetts is entitled to pursue a new theory of liability against drugmaker Amgen Inc. over the death of her 25-year-old son after he took the company's then-recently approved migraine...To view the full article, register now.
Already a subscriber? Click here to view full article